Marc Bisschops, PhD
Pall Life Sciences
Principal Scientist, Biopharm
Within Pall, Marc is responsible for development and implementation of continuous bioprocessing technologies.
<br><br>
Prior to joining Pall, Marc was CSO at Tarpon Biosystems, the company that developed the BioSMB® technology. Marc held several scientific and management positions in the field of process development departments in Batavia Biosciences, Xendo. He has established a significant track record in completing projects related to continuous chromatography and continuous downstream processing. With over 250 projects completed, he is one of the leading scientists in this area.
<br><br>
Marc holds a PhD in biochemical engineering and an MSc in chemical engineering from Delft University in The Netherlands. He is listed as (primary) inventor on various patents related to continuous process technologies. He is a lecturer in in various post-graduate courses in Europe.
<br><br>
Prior to joining Pall, Marc was CSO at Tarpon Biosystems, the company that developed the BioSMB® technology. Marc held several scientific and management positions in the field of process development departments in Batavia Biosciences, Xendo. He has established a significant track record in completing projects related to continuous chromatography and continuous downstream processing. With over 250 projects completed, he is one of the leading scientists in this area.
<br><br>
Marc holds a PhD in biochemical engineering and an MSc in chemical engineering from Delft University in The Netherlands. He is listed as (primary) inventor on various patents related to continuous process technologies. He is a lecturer in in various post-graduate courses in Europe.